SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
ImmuLogic
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
23 1 0 IMUL
Emcee:  Paul Getman Type:  Unmoderated
Introduction Market Data Compact
No one seemed to notice, but IMUL got a nice $700K grant this week to help the company's research for its cocaine vaccine. This is IMUL's third major research program, after allergies (2 Phase III trials underway) and MS (1 Phase I trial to start shortly). Next up after cocaine will be vaccines for poison ivy.

The stock's starting to move up, but I doubt it will go very far until IMUL announces its new partner for its Allervax programs. Hopefully we'll hear more about this before year end.

Paul
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
23 Is there another thread on IMUL?? Does Sturza have anything specific to say aboBhag Karamchandani-12/6/1996
22 Todd, I have no idea. On the other thread on this subject, Michael Collins saiRick Strange-12/5/1996
21 To All. Any thoughts on why the CEO and CFO resigned. Obviously, this is not Todd King-12/5/1996
20 Hambrecht & Quist started coverage of IMUL with a buy rating based upon twoRick Strange-11/26/1996
19 Nothing that can not be read from the annual report. The main thing I have heamike wirtz-11/24/1996
18 Mike, I noticed you indicated you own some Poss, I do also. Have you heard anyRichard D. Brennan-11/24/1996
17 Hi Paul, New to the SI. Will you still be posting on AOL? I see there are tRob-11/24/1996
16 The FDA assigns an IND for Phase I, II, or III trials. A good example of this mike wirtz-11/22/1996
15 I'm not sure what you're asking. IMUL has not applied for regulatory apPaul Getman-11/21/1996
14 Do you have the IND (investigational new drug) for ALLERVAX cat and Ragweed, somike wirtz-11/19/1996
13 Yesterday's WSJ had nice article on anti-cocaine vaccine. IMUL estimates David Bleich-10/2/1996
12 Harold: I am happy if IMUL goes up and happy if it goes down (I'll buy morDavid Bleich-9/30/1996
11 Any thoughts about the last two days' retrenchment? Harold EngstromHarold Engstrom-9/30/1996
10 Paul: Nice volume and follow through today for IMUL. This to me is a definiteDavid Bleich-9/26/1996
9 I think $25 to $30 is on the mark if IMUL gets approval for both Allervax Cat aPaul Getman-9/25/1996
8 Paul: This is great news. My clinical impression is that most patients with sDavid Bleich-9/24/1996
7 A new research report on IMUL has been issued by Punk Ziegel & Knoell. TheyPaul Getman-9/23/1996
6 I attended a presentation and break-out session given in early September by IMUPaul Getman-9/22/1996
5 Paul: Great article in Health Journal of WSJ today on allergy suffers. This mDavid Bleich-9/17/1996
4 IMUL has $75 million in cash as of second quarter 1996. (IMUL's cash is in Paul Getman-8/31/1996
3 Thanks will continue research and post same.John A. Anderfuren-8/27/1996
2 John: My understanding is that IMUL has about $45 million in cash which shouldDavid Bleich-8/27/1996
1 Follow up a lead from another string, I research IMUL. The numbers are not veJohn A. Anderfuren-8/25/1996
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2021 Knight Sac Media.  Data provided by IEX, Alpha Vantage, Coinbase, Binance, Fintel and CityFALCON News